Skip to main content
. 2022 Oct 28;9(11):ofac558. doi: 10.1093/ofid/ofac558

Table 1.

Characteristics of the Study Population by Sex (N = 1206)

Characteristic Women (n = 507) Men
(n = 698)
P Value
Region of enrollment .06
 Ziguinchor 276 (54.4) 419 (60.0)
 Dakar 231 (45.6) 279 (40.0)
Age at enrollment, y, median (IQR) 32 (26–39) 32 (26–40) .53
 Age >30 y 273 (54.1) 390 (56.2) .46
Screening reasons <.001
 Community/family testing 73 (15.4) 68 (10.5)
 Antenatal care 184 (38.8) 0 (0.0)
 Blood donation 98 (20.7) 355 (54.7)
 Routine check-up 119 (25.1) 226 (34.8)
Alcohol consumption 28 (5.9) 63 (10.7) .01
Family history of HCCa 51 (19.2) 44 (13.8) .08
HBeAg positiveb 7 (3.0) 3 (1.0) .08
ALT, IU/L, median (IQR) 15 (10–22.45) 19 (14–26) <.001
ALT >40 IU/L 30 (6.4) 69 (10.3) .02
HBV DNA, IU/mL, median (IQR)c 509 (38–2906) 648 (115–3380) .04
 Category .12
  <20 85 (20.0) 86 (14.3)
  20–2000 214 (50.4) 320 (53.2)
  2001–2000 93 (21.9) 145 (24.1)
  >20 000 33 (7.8) 50 (8.3)
LSM, kPa, median (IQR) 4.7 (4–5.6) 5.5 (4.5–6.5) <.001
 Category <.001
  ≤7.0 478 (94.3) 579 (83.1)
  7.1–11.0 24 (4.7) 91 (13.1)
  >11.0 5 (1.0) 27 (3.9)

Data are presented as No. (%) unless otherwise indicated. Some characteristics have different denominators because of missing data.

Abbreviations: ALT, alanine aminotransferase; HBeAg, hepatitis B envelope antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; IQR, interquartile range; LSM, liver stiffness measurement.

a

Data available for 584 individuals.

b

Data available for 540 individuals.

c

Data available for 1026 individuals. We excluded 1 individual without data on sex.